{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.11.1155","meta":{"versionId":"16","lastUpdated":"2021-09-23T01:03:11.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-09-23"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.110.11.1155"}],"version":"20210923","name":"HiBVaccine4DoseScheduleAdministered","title":"HiB Vaccine (4 dose schedule) Administered","status":"active","experimental":false,"date":"2021-09-23T01:03:11-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: The purpose of this value set is to represent concepts for a 4-dose haemophilus influenzae type b (Hib) vaccines.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for a 4-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"90644","display":"Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"},{"code":"90648","display":"Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"},{"code":"90698","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"}]}]},"expansion":{"identifier":"urn:uuid:a31370d9-ccb8-4322-b229-0905c820639b","timestamp":"2023-12-11T02:10:33-05:00","total":3,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90644","display":"Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90648","display":"Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"90698","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"}]}}